Phase 2 study to examine how the study drug works and its side effects in subjects with toenail fungus.
| Condition | Intervention | Phase |
|---|---|---|
| Onychomycosis | Drug: Albaconazole 100mg Drug: Albaconazole 200mg Drug: Albaconazole 400mg Drug: Placebo 400 mg |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the Efficacy and Safety of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis |
Date of article/Start date of trial: 4 August 2008
Trial Phase: Phase 2
clinical Trials Gov ID: NCT00730405
Trial status: Completed